| Filed On | Filing |
|---|---|
| 21 Feb 2018 |
Form 3: Borkowski Edward, CHIEF FINANCIAL OFFICER
Holds 0 shares of COMMON STOCK |
| 13 Nov 2017 |
Form 3: Scally Frances P, SVP, CHIEF ACCOUNTING OFFICER
Holds 18,798.8 shares of COMMON STOCK |
| 09 Sep 2016 |
Form 3: Kennally William C. Iii, Director
Holds 0 shares of COMMON STOCK |
| 01 Aug 2016 |
Form 3: Kaczmarek Walter J Iii, Chief Operating Officer
Holds 0 shares of COMMON STOCK |
| 26 Sep 2014 |
Form 3: Yarosh Daniel B., Director
Holds 0 shares of Common Stock |
| 03 Mar 2014 |
Form 3: Restrepo Carlos, Sr. Vice President
Holds 5,000 shares of Common Stock |
| 25 Feb 2014 |
Form 3: Kippley Terry, Sr. Vice President
Holds 17,839 shares of Common Stock |
| 10 Dec 2013 |
Form 3: Levin Alan G, Director
Holds 2,164 shares of Common Stock |
| 30 Jul 2013 |
Form 3: Srinivasan Satish, President & COO-Rising Pharma.
Holds 12,500 shares of Common Stock |
| 03 Jul 2012 |
Form 3: Hippel Lukas von, Managing Director
Holds 0 shares of Common Stock |
| 02 Jul 2012 |
Form 3: Alaimo Charles John, Vice President
Holds 2,000 shares of Common Stock |
| 16 Dec 2011 |
Form 3: Giordano Natasha, Director
Holds 0 shares of Common Stock |
| 14 Sep 2011 |
Form 3: Shackley Nicolas I, Sr. Vice Prsident - API
Holds 0 shares of Common Stock |
| 14 Sep 2011 |
Form 3: Rogers Steven, V.P. & General Counsel
Holds 2,000 shares of Common Stock |
| 13 May 2011 |
Form 3: Guccione Salvatore J Sr, Director
Holds 0 shares of Common Stock |
| 14 Feb 2011 |
Form 3: Saint-Clair Guillaume, Int'l VP Pharma Intermediates
Holds 467 shares of Common Stock |
| 10 Jan 2011 |
Form 3: Rosen David B., Senior V.P. - Rising Pharm.
Holds 1,000,000 shares of Common Stock |
| 10 Jan 2011 |
Form 3: Gold Ronald, President & COO-Rising Pharm.
Holds 1,000,000 shares of Common Stock |
| 25 Jun 2010 | Form 3: Bender Ulf, Managing Director |
| 18 Dec 2009 |
Form 3: Van Els Jan, Managing Director
Holds 1,064 shares of Common Stock |
Loading...
